Current status: 1111 hESC lines, 7386 hiPSC lines, and 182 clinical studies, and 2398 certificates
Monthly statistic from Oct 1, 2025
Posted on October 1, 2025
total lines | 8497 |
hESC lines | 1111 |
hiPSC lines | 7386 |
derivation countries | 52 |
projects | 328 |
providers | 1017 |
clinical studies | 182 |
subclones | 3776 |
certificates | 2398 |
cell line certificates | 2246 |
project certificates | 152 |